Shares of AbbVie Inc. ABBV shed 2.78% to $176.46 Wednesday, on what proved to be an all-around positive trading session for ...

Top 15. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend kings ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

AbbVie Inc (ABBV) stock saw a decline, ending the day at $181.5 which represents a decrease of $-0.27 or -0.15% from the prior close of $181.77. The stock opened at $182.28 and touched a low of ...

Former AbbVie CEO Richard Gonzalez sold his Hidden Hills home for $21.7 million in the pharma executive’s latest real estate ...

On Friday, AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $183.34 which represents a slight increase of $0.26 or 0.14% from the prior close of $183.08. The stock opened at $183.11 and ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other most undervalued pot stocks to buy according to analysts. A decade ago, the cannabis industry was ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other most profitable pharmaceutical stocks. Healthcare, which includes numerous businesses that ...

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...